Dr. Ferdinand Rivera Ortiz, M.D

NPI: 1174554356
Total Payments
$914.32
2024 Payments
$253.49
Companies
13
Transactions
37
Medicare Patients
66
Medicare Billing
$7,477

Payment Breakdown by Category

Food & Beverage$914.32 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $914.32 37 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $334.83 16 $0 (2024)
AstraZeneca Pharmaceuticals LP $200.09 6 $0 (2024)
Merck Sharp & Dohme LLC $144.85 3 $0 (2024)
PBG PUERTO RICO LLC $44.07 2 $0 (2024)
Horizon Pharma plc $40.40 1 $0 (2018)
SANOFI-AVENTIS U.S. LLC $29.52 2 $0 (2017)
Genentech USA, Inc. $20.66 1 $0 (2024)
E.R. Squibb & Sons, L.L.C. $18.67 1 $0 (2018)
AbbVie, Inc. $18.33 1 $0 (2019)
CALLIDITAS THERAPEUTICS US INC. $17.60 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $253.49 12 Janssen Pharmaceuticals, Inc ($138.57)
2023 $291.16 10 AstraZeneca Pharmaceuticals LP ($185.03)
2022 $20.00 1 Janssen Pharmaceuticals, Inc ($20.00)
2021 $55.42 3 Janssen Pharmaceuticals, Inc ($55.42)
2020 $49.30 3 Janssen Pharmaceuticals, Inc ($33.78)
2019 $18.33 1 AbbVie, Inc. ($18.33)
2018 $59.07 2 Horizon Pharma plc ($40.40)
2017 $167.55 5 Merck Sharp & Dohme Corporation ($124.85)

All Payment Transactions

37 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/12/2024 Janssen Pharmaceuticals, Inc DARZALEX (Biological) Food and Beverage In-kind items and services $24.08 General
Category: Oncology
11/12/2024 Janssen Pharmaceuticals, Inc DARZALEX (Biological) Food and Beverage In-kind items and services $23.00 General
Category: Oncology
09/12/2024 Janssen Pharmaceuticals, Inc DARZALEX (Biological) Food and Beverage In-kind items and services $23.54 General
Category: Oncology
08/22/2024 Janssen Pharmaceuticals, Inc DARZALEX (Biological) Food and Beverage In-kind items and services $25.00 General
Category: Oncology
08/07/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $17.60 General
Category: Nephrology
07/17/2024 Janssen Pharmaceuticals, Inc DARZALEX (Biological) Food and Beverage In-kind items and services $25.00 General
Category: Oncology
07/11/2024 SOBI, INC VONJO (Drug) Food and Beverage In-kind items and services $16.60 General
Category: HEMATOLOGY/ONCOLOGY
04/24/2024 Genentech USA, Inc. Columvi (Biological), Lunsumio, Polivy Food and Beverage In-kind items and services $20.66 General
Category: BioOncology
04/10/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $15.06 General
Category: Cardiovascular and Metabolism
04/04/2024 Janssen Pharmaceuticals, Inc IMBRUVICA (Drug) Food and Beverage In-kind items and services $17.95 General
Category: Oncology
02/22/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $20.00 General
Category: ONCOLOGY
02/15/2024 PBG PUERTO RICO LLC OXBRYTA (Drug) Food and Beverage In-kind items and services $25.00 General
Category: HEMATOLOGY
12/13/2023 Janssen Pharmaceuticals, Inc DARZALEX (Biological) Food and Beverage In-kind items and services $20.00 General
Category: Oncology
10/11/2023 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $13.44 General
Category: Cardiovascular and Metabolism
09/20/2023 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $14.30 General
Category: Cardiovascular and Metabolism
09/14/2023 Janssen Pharmaceuticals, Inc IMBRUVICA (Drug) Food and Beverage In-kind items and services $22.61 General
Category: Oncology
08/17/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular and Metabolism
07/06/2023 PBG PUERTO RICO LLC OXBRYTA (Drug) Food and Beverage In-kind items and services $19.07 General
Category: HEMATOLOGY
05/24/2023 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $18.63 General
Category: Cardiovascular and Metabolism
04/26/2023 Janssen Pharmaceuticals, Inc ERLEADA (Drug) Food and Beverage In-kind items and services $22.45 General
Category: Oncology
03/16/2023 Janssen Pharmaceuticals, Inc DARZALEX (Biological), TECVAYLI Food and Beverage In-kind items and services $22.00 General
Category: Oncology
01/27/2023 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $13.67 General
Category: Cardiovascular and Metabolism
08/04/2022 Janssen Pharmaceuticals, Inc DARZALEX (Biological), IMBRUVICA Food and Beverage In-kind items and services $20.00 General
Category: Oncology
08/11/2021 Janssen Pharmaceuticals, Inc IMBRUVICA (Drug) Food and Beverage In-kind items and services $20.00 General
Category: Oncology
06/24/2021 Janssen Pharmaceuticals, Inc IMBRUVICA (Drug) Food and Beverage In-kind items and services $18.48 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 13 33 $3,106 $1,961
2022 1 14 38 $2,945 $2,203
2020 2 39 51 $4,604 $3,313
Total Patients
66
Total Services
122
Medicare Billing
$7,477
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 33 $3,106 $1,961 63.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 14 38 $2,945 $2,203 74.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 21 30 $2,278 $1,684 73.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 18 21 $2,326 $1,629 70.0%

About Dr. Ferdinand Rivera Ortiz, M.D

Dr. Ferdinand Rivera Ortiz, M.D is a Nephrology healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174554356.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ferdinand Rivera Ortiz, M.D has received a total of $914.32 in payments from pharmaceutical and medical device companies, with $253.49 received in 2024. These payments were reported across 37 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($914.32).

As a Medicare-enrolled provider, Rivera Ortiz has provided services to 66 Medicare beneficiaries, totaling 122 services with total Medicare billing of $7,477. Data is available for 3 years (2020–2023), covering 4 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location San Juan, PR
  • Active Since 07/05/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1174554356

Products in Payments

  • DARZALEX (Biological) $199.28
  • FARXIGA (Drug) $124.99
  • IMBRUVICA (Drug) $113.10
  • ZEPATIER (Drug) $104.94
  • LOKELMA (Drug) $75.10
  • OXBRYTA (Drug) $44.07
  • KRYSTEXXA (Drug) $40.40
  • THYMOGLOBULIN (Drug) $29.52
  • ERLEADA (Drug) $22.45
  • Columvi (Biological) $20.66
  • KEYTRUDA (Biological) $20.00
  • ELIQUIS (Drug) $18.67
  • Venclexta (Drug) $18.33
  • TARPEYO (Drug) $17.60
  • VONJO (Drug) $16.60
  • MVASI (Biological) $15.52
  • PREVNAR - 13 (Biological) $13.18

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in San Juan